Compile Data Set for Download or QSAR
Report error Found 498 Enz. Inhib. hit(s) with Target = 'Glutamate receptor ionotropic, NMDA 1/2C'
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50111396([[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,...)
Affinity DataKi:  11.6nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583031(CHEMBL5081078)
Affinity DataEC50:  36nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583020(CHEMBL5087374)
Affinity DataEC50:  40nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557699(US11466027, Compound 1l | US11358971, Compound 1h)
Affinity DataKi:  63nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583019(CHEMBL5081008)
Affinity DataEC50:  63nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50419775(CHEMBL1950808)
Affinity DataKi:  70nMAssay Description:Antagonist activity rat recombinant GluN1/GluN2C receptor expressed in Xenopus laevis oocytes assessed as inhibition of glutamate-induced response by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583032(CHEMBL5090386)
Affinity DataEC50:  74nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164540((2R,3S)-1-(Phenanthrene-2-carbonyl)-piperazine-2,3...)
Affinity DataKi:  96nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557694(US11466027, Compound 1e | US11358971, Compound 1c)
Affinity DataKi:  96nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164549((2R,3S)-1-(7-Bromo-phenanthrene-2-carbonyl)-pipera...)
Affinity DataKi:  99.4nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164549((2R,3S)-1-(7-Bromo-phenanthrene-2-carbonyl)-pipera...)
Affinity DataKi:  100nMAssay Description:Antagonist activity rat recombinant GluN1/GluN2C receptor expressed in Xenopus laevis oocytes assessed as inhibition of glutamate-induced response by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50220152(2-(Amino-carboxy-methyl)-cyclopropanecarboxylic ac...)
Affinity DataEC50:  110nMAssay Description:Agonist activity at rat recombinant wild type GluN1/GluN2C receptor expressed in Xenopus laevis oocytes by two electrode voltage clamp techniqueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583021(CHEMBL5091289)
Affinity DataEC50:  110nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583023(CHEMBL5081203)
Affinity DataEC50:  120nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50432711(CHEMBL2348224)
Affinity DataEC50:  124nMAssay Description:Agonist activity at rat recombinant wild type GluN1/GluN2C receptor expressed in Xenopus laevis oocytes by two electrode voltage clamp techniqueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50583022(CHEMBL5085583)
Affinity DataEC50:  140nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557693(US11466027, Compound 1d | US11358971, Compound 1b)
Affinity DataKi:  140nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Human)
Sage Therapeutics

Curated by ChEMBL
LigandPNGBDBM50597430(Dalzanemdor | DALZANEMDOR)
Affinity DataEC50:  150nMAssay Description:Positive allosteric modulation of recombinant human GluN1/GluN2C receptor stably expressed in HEK293 cells assessed as increase in glycine/L-glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557667(US11466027, Compound 1c | US11358971, Compound 1a)
Affinity DataKi:  170nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557701(US11466027, Compound 1n | US11358971, Compound 1j)
Affinity DataKi:  180nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM23167((2R)-2-amino-3-hydroxypropanoic acid | CHEMBL28512...)
Affinity DataEC50:  190nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM18133(2-aminoacetic acid | [14C]Glycine | CHEMBL773 | Gl...)
Affinity DataEC50:  210nMAssay Description:Agonist activity at rat GluN1/GluN2C NMDA receptor expressed in Xenopus oocytes measured after 4 days in presence of L-glutamte by two-electrode volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM576021(US11466027, Compound 1f | (R)-2-amino-3-[(7- isopr...)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557698(US11466027, Compound 1k | US11358971, Compound 1g)
Affinity DataKi:  220nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557702(US11466027, Compound 1o | US11358971, Compound 1k)
Affinity DataKi:  260nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM576017(US11466027, Compound 1b | (R)-2-amino-3-[(7- ethyl...)
Affinity DataKi:  270nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164555((2R,3S)-1-(9,10-Dihydro-phenanthrene-2-carbonyl)-p...)
Affinity DataKi:  290nMAssay Description:Antagonist activity rat recombinant GluN1/GluN2C receptor expressed in Xenopus laevis oocytes assessed as inhibition of glutamate-induced response by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164555((2R,3S)-1-(9,10-Dihydro-phenanthrene-2-carbonyl)-p...)
Affinity DataKi:  290nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50436093(CHEMBL2397268)
Affinity DataEC50:  300nMAssay Description:Activity at rat recombinant GluN1/GluN2C receptor assessed as potentiation of glycine/glutamate-induced activation by two-electrode voltage clamp tec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238357(CHEMBL4100452)
Affinity DataEC50:  340nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238363(CHEMBL4099510)
Affinity DataEC50:  350nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238354(CHEMBL4070902)
Affinity DataEC50:  350nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557697(US11466027, Compound 1i | US11358971, Compound 1f)
Affinity DataKi:  360nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238335(CHEMBL4083076)
Affinity DataEC50:  380nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50545698(CHEMBL4637429)
Affinity DataEC50:  398nMAssay Description:Positive allosteric modulation of recombinant rat GluN1a/GluN2C receptor expressed in Xenopus laevis oocytes assessed as increase in glycine/L-glutam...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50545700(CHEMBL4633060)
Affinity DataEC50:  398nMAssay Description:Positive allosteric modulation of recombinant rat GluN1a/GluN2C receptor expressed in Xenopus laevis oocytes assessed as increase in glycine/L-glutam...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50545699(CHEMBL4636021)
Affinity DataEC50:  398nMAssay Description:Positive allosteric modulation of recombinant rat GluN1a/GluN2C receptor expressed in Xenopus laevis oocytes assessed as increase in glycine/L-glutam...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50436094(CHEMBL2397267)
Affinity DataEC50:  400nMAssay Description:Activity at rat recombinant GluN1/GluN2C receptor assessed as potentiation of glycine/glutamate-induced activation by two-electrode voltage clamp tec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Human)
Sage Therapeutics

Curated by ChEMBL
LigandPNGBDBM50498430(CHEMBL3594112)
Affinity DataIC50: 400nMAssay Description:Inhibition of recombinant GluN1/GluN2C receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of glutamate-evoked current by whol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2020
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238350(CHEMBL4063861)
Affinity DataEC50:  420nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238355(CHEMBL4091770)
Affinity DataEC50:  480nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238364(CHEMBL4064008)
Affinity DataEC50:  480nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557703(US11466027, Compound 1p | US11358971, Compound 1l)
Affinity DataKi:  490nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50432710(CHEMBL2348221)
Affinity DataEC50:  540nMAssay Description:Agonist activity at rat recombinant wild type GluN1/GluN2C receptor expressed in Xenopus laevis oocytes by two electrode voltage clamp techniqueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2013
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50050704((R)-4-(3-phosphonopropyl)piperazine-2-carboxylic a...)
Affinity DataKi:  630nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164548((2R,3S)-1-(7-Bromo-9,10-dihydro-phenanthrene-2-car...)
Affinity DataKi:  660nMAssay Description:Inhibitory constant against (S)-glutamate and glycine evoked currents mediated by N-methyl-D-aspartate glutamate receptor NR1a/NR2C expressed in Xeno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50164548((2R,3S)-1-(7-Bromo-9,10-dihydro-phenanthrene-2-car...)
Affinity DataKi:  660nMAssay Description:Antagonist activity rat recombinant GluN1/GluN2C receptor expressed in Xenopus laevis oocytes assessed as inhibition of glutamate-induced response by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C/3B(Human)
H. Lundbeck

US Patent
LigandPNGBDBM557696(US11466027, Compound 1h | US11358971, Compound 1e)
Affinity DataKi:  690nMAssay Description:To determine the affinity of the compounds of the present invention a SPA is used. The assay is run in a 384-plate format (OptiPlate-384) where each ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50238341(CHEMBL4064435)
Affinity DataEC50:  690nMAssay Description:Positive allosteric modulation of recombinant rat GluN1/GluN2C receptor expressed in xenopus laevis oocyte assessed as potentiation of glutamate and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2019
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 1/2C(Rat)
University Walk

Curated by ChEMBL
LigandPNGBDBM50436095(CHEMBL2397266)
Affinity DataEC50:  700nMAssay Description:Activity at rat recombinant GluN1/GluN2C receptor assessed as potentiation of glycine/glutamate-induced activation by two-electrode voltage clamp tec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
Displayed 1 to 50 (of 498 total ) | Next | Last >>
Jump to: